Glenvas 4 – Lenvatinib 4 Mg Capsule

Lenvatinib 4 mg Capsule is an oral medication used primarily in the treatment of several cancers, including differentiated thyroid cancer, renal cell carcinoma (RCC), and hepatocellular carcinoma (HCC). It is classified as a multikinase inhibitor and works by blocking various enzymes that promote cancer cell growth and angiogenesis (the formation of new blood vessels that supply nutrients to tumors). This targeted therapy helps to slow down the progression of cancer, offering a vital treatment option for patients with advanced stages of these cancers.

Lenvatinib 4 mg Capsule: Key Uses

• Differentiated Thyroid Cancer (DTC): Lenvatinib is used for the treatment of advanced or metastatic differentiated thyroid cancer that no longer responds to radioactive iodine therapy. It works by inhibiting the growth of cancer cells and the formation of blood vessels that tumors need to thrive.
• Renal Cell Carcinoma (RCC): In patients with advanced renal cell carcinoma (a type of kidney cancer), Lenvatinib is used, often in combination with everolimus. It helps to inhibit tumor growth by targeting key growth factors involved in cancer cell proliferation and blood vessel formation.
• Hepatocellular Carcinoma (HCC): For patients with advanced liver cancer (hepatocellular carcinoma), Lenvatinib can be used as a first-line treatment, providing an important option for managing liver tumors that are difficult to treat with other therapies.

How Lenvatinib 4 mg Capsule Works

Lenvatinib works by targeting and blocking the activity of several receptor tyrosine kinases (RTKs) involved in tumor growth and angiogenesis. These include vascular endothelial growth factor receptors (VEGFRs), fibroblast growth factor receptors (FGFRs), and platelet-derived growth factor receptors (PDGFRs). By inhibiting these receptors, Lenvatinib prevents tumors from forming new blood vessels and receiving the nutrients they need to grow.

Lenvatinib’s ability to block multiple kinases involved in cancer progression makes it effective in treating cancers like differentiated thyroid cancer, kidney cancer, and liver cancer. The 4 mg capsule is typically taken once daily, and the dosage may be adjusted based on the patient’s condition and response to treatment.

Side Effects of Lenvatinib 4 mg Capsule

Like other cancer treatments, Lenvatinib can cause side effects, which can range from mild to severe. It’s essential to monitor for side effects and discuss them with a healthcare provider.

• Common Side Effects:
  • Fatigue or tiredness
  • Diarrhea
  • Decreased appetite and weight loss
  • Nausea or vomiting
  • High blood pressure (hypertension)
  • Mouth sores or mucositis
  • Proteinuria (excess protein in urine)
  • Joint pain or stiffness
  • Hair thinning or hair loss

Ameridrugs: Trusted Pharmaceutical Exporter Worldwide

At Ameridrugs, we are a trusted pharmaceutical exporter offering Lenvatinib 4 mg Capsules to patients worldwide. With a reputation for reliability and commitment to quality, we ensure that our products meet the highest standards of safety and efficacy.

• Fastest Shipping (6-8 Days): When you order Lenvatinib 4 mg Capsules from Ameridrugs, you can expect 6 to 8 days fastest shipping to the USA, UK, and other international destinations. We understand the importance of timely treatment and ensure prompt delivery.
• Global Reach: No matter where you are located—in the USA, UK, or beyond—Ameridrugs provides secure, efficient shipping of Lenvatinib 4 mg Capsules and other essential medications to patients around the world.
• Reliable Ordering Process: Ordering from Ameridrugs is easy and secure. Our user-friendly website ensures a smooth and safe transaction, and our customer support team is always available to assist with any questions.
• Authentic and High-Quality Products: We only source our medications from trusted and licensed manufacturers, ensuring that you receive genuine and effective products every time.

Conclusion

Lenvatinib 4 mg Capsules offer a critical treatment option for patients with advanced differentiated thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. By targeting multiple kinases involved in tumor growth and angiogenesis, Lenvatinib helps slow the progression of these cancers and improves patient outcomes. While side effects are possible, they can often be managed with the right medical guidance.